Results 11 to 20 of about 4,067,094 (305)

Excess deaths from all causes and by COVID-19 in Brazil in 2020 [PDF]

open access: yesRevista de Saúde Pública, 2021
OBJECTIVE To estimate the 2020 all-cause and COVID-19 excess mortality according to sex, age, race/color, and state, and to compare mortality rates by selected causes with that of the five previous years in Brazil. METHODS Data from the Mortality Information System were used.
Alcione Miranda dos Santos   +10 more
openaire   +6 more sources

HYPERTENSION MANAGEMENT IN ALL CAUSE SUDDEN DEATH

open access: yesJournal of the American College of Cardiology, 2020
Patients with hypertension (HTN) have increased risk of sudden death, but blood pressure control in sudden death is not clear. To better understand potential opportunities to prevent sudden death, we assessed blood pressures, comorbidities and control among all cause sudden death victims.
Albert Chang   +10 more
openaire   +1 more source

All-cause excess mortality and COVID-19-related deaths in Iran [PDF]

open access: yesMedical Journal of The Islamic Republic of Iran, 2020
Background: Iran reported its first COVID-19 deaths on February 19, 2020 and announced 1284 deaths with a laboratory-confirmed SARS-CoV-2 infection by March 19, 2020 (end of the winter 1398 SH). We estimated all-cause excess mortality, compared to the historical trends, to obtain an indirect estimate of COVID-19-related deaths.
Tadbiri, Hooman   +2 more
openaire   +2 more sources

Resistin as a risk factor for all-cause (and cardiovascular) death in the general population

open access: yesScientific Reports, 2022
AbstractSerum resistin is a pro-inflammatory cytokine that has been described as a risk factor associated with mortality in several clinical sets including type 2 diabetes. Mortality studies in the general population are needed to find out the risk of death associated to this cytokine.
María del Cristo Rodríguez Pérez   +6 more
openaire   +3 more sources

The Persistent Southern Disadvantage in Us Early Life Mortality, 1965‒2014 [PDF]

open access: yes, 2020
Background: Recent studies of US adult mortality demonstrate a growing disadvantage among southern states. Few studies have examined long-term trends and geographic patterns in US early life (ages 1 to 24) mortality, ages at which key risk factors and ...
Braudt, David B.   +6 more
core   +3 more sources

All-Cause Death Prediction Method for CHD Based on Graph Convolutional Networks. [PDF]

open access: yesComput Intell Neurosci, 2022
Coronary heart disease (CHD) has become one of the most serious public health issues due to its high morbidity and mortality rates. Most of the existing coronary heart disease risk prediction models manually extract features based on shallow machine learning methods.
Xue Y, Chen K, Lin H, Zhong S.
europepmc   +3 more sources

Major Outcomes in Atrial Fibrillation Patients with One Risk Factor: Impact of Time in Therapeutic Range [PDF]

open access: yes, 2016
BACKGROUND: The benefits and harms of oral anticoagulation (OAC) therapy in patients with only one stroke risk factor (i.e. CHA2DS2-VASc= 1 in males, or 2 in females) has been subject of debate.
Lip, Gregory Y. H., Proietti, Marco
core   +2 more sources

Renal dysfunction improves risk stratification and may call for a change in the management of intermediate- and high-risk acute pulmonary embolism: results from a multicenter cohort study with external validation

open access: yesCritical Care, 2021
Background Renal dysfunction influences outcomes after pulmonary embolism (PE). We aimed to determine the incremental value of adding renal dysfunction, defined by estimated glomerular filtration rate (eGFR), on top of the European Society of Cardiology (
Romain Chopard   +11 more
doaj   +1 more source

Lipid levels are inversely associated with infectious and all-cause mortality: international MONDO study results. [PDF]

open access: yes, 2018
Cardiovascular (CV) events are increased 36-fold in patients with end-stage renal disease. However, randomized controlled trials to lower LDL cholesterol (LDL-C) and serum total cholesterol (TC) have not shown significant mortality improvements.
Canaud, Bernard   +11 more
core   +3 more sources

Home - About - Disclaimer - Privacy